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Abstract: Increased breast cancer risk has been reported in some night shift (NS) workers but
underlying biological mechanisms are still unclear. We assessed the association between NS work
and DNA methylation of tumor suppressor (TP53, CDKN2A, BRCA1, BRCA2) and estrogen receptor
(ESR1, ESR2) genes, methylation of repetitive elements (LINE-1, Alu), and telomere length (TL). Forty
six female nurses employed in NS for at least two years were matched by age (30–45 years) and
length of service (≥1 year) with 51 female colleagues not working in NS. Each subject underwent a
semi-structured interview and gave a blood sample. We applied linear regression and spline models
adjusted for age, BMI, smoking habit, oral contraceptive use, parity and marital status/age at marriage.
Currently working in NS was associated with ESR1 hypomethylation (β: −1.85 (95%CI: −3.03; −0.67),
p = 0.003). In current and former NS workers we observed TP53 (−0.93 (−1.73; −0.12), p = 0.03) and
BRCA1 (−1.14 (−1.71; −0.58), p <0.001) hypomethylation. We found an increase between TL and
number of years in NS in subjects employed in NS <12 years (0.06 (0.03; 0.09), p <0.001), while a
decrease if employed in NS≥12 years (−0.07−0.10; −0.04), p <0.001). Our findings show NS-associated
markers potentially involved in cellular aging, genomic instability, and cancer development.
Keywords: night shift work; breast cancer; DNA methylation; telomere length; female nurses
1. Introduction
Shift work which causes circadian disruption has been classified as “probably carcinogenic to
humans” (Group 2A) by the International Agency for Research on Cancer (IARC) [1], on the basis of
limited evidence in humans. Most epidemiological studies considered in IARC evaluation examined
breast cancer risk, with the most relevant evidence coming from two prospective cohort studies that
showed an increased risk in a subgroup of female nurses after over 20–30 years of rotating night shift
work [2,3].
Several other investigations have been published since, most of which collectively indicate a
tendency of increased risk of breast cancer, especially in workers employed in night shifts for several
years [4] or in schedules characterized by many consecutive night shifts [5]. Nonetheless, an overall
heterogeneity characterizes these studies, mostly due to lack of a standard definition of exposure,
differences in study design, missing information on chronotype, differences in the menopausal status
of the investigated populations and in breast cancer subtypes [6].
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The mechanisms hypothesized for the association between circadian disruption and the induction
and/or promotion of malignant tumors are multifactorial [7]: repeated phase shifting and consequent
defects in circadian cell-cycle regulation may favor uncontrolled cell growth; melatonin suppression
may lead to an up-regulation of the effects of estrogen upon the breast epithelial cell; sleep deprivation
is known to suppress immune surveillance, thus potentially allowing the formation and/or growth of
malignant clones. However, none of the identified factors seems to be the only responsible for the
moderately increased cancer rate among shift workers.
Epigenetic mechanisms mediate the adaptation of the genome to environmental stimuli, and
epigenetic alterations can contribute to the development of disease phenotypes resembling genetic
mutations [8]. In recent years, a growing body of evidence has focused on epigenetic modifications
as potential mechanism underlying several diseases, including cancer, cardiovascular, respiratory,
and neurodegenerative diseases [9,10]. DNA methylation, a process characterized by addition of
methyl (-CH3) groups to the DNA molecule, represents the most frequent epigenetic modifications in
eukaryotic DNA [11] and is involved in regulating many cellular processes, including chromosome
stability and gene transcription [12]. Altered DNA methylation patterns in the promoter regions of
several genes have been associated with increased cancer risk [13]. In addition, reduced methylation of
repetitive elements such as LINE-1 and Alu has been associated with genomic instability [14,15]. On the
other hand, telomeres are the non-coding terminal regions of the chromosomes which consist of highly
repeated sequences. Their length is influenced by several physiologic, lifestyle, and environmental
factors, including ageing, smoking habit, psychological stress, overweight/obesity, and exposure
to pollutants [16]. Altered telomere length has been also associated with night shift work [17–19].
In addition, genomic instability following telomere shortening represents a recognized mechanism of
cancer development [20].
We thus established the present study to assess the association between night shift work and
molecular alterations potentially related to a higher carcinogenic risk. We focused our analysis on DNA
methylation of estrogen receptor genes (ESR1, ESR2) and the tumor suppressor genes TP53, CDKN2A,
BRCA1, BRCA2 which play a relevant role in key cellular processes such as cell growth, apoptosis,
and DNA repair and have been associated (with different mechanisms) with increased breast cancer
risk [21–24]; methylation of repetitive elements (LINE-1, Alu); and telomere length.
2. Materials and Methods
2.1. Study Population
The study population has been recruited, on a voluntary basis, among the female nurses employed
at the Fondazione IRCCS Ca’ Granda Policlinico Hospital in Milan, Italy. Invitation for participation
was proposed by the Occupational Health Physician of the hospital, during the routine visits of the
workers’ health surveillance program. All subjects gave their informed consent for inclusion before they
participated in the study. The study was conducted in accordance with the Declaration of Helsinki [25],
and the protocol was approved by the Institutional Review Board of the Policlinico Hospital.
To be eligible for inclusion in the study, subjects had to be female nurses of Caucasian ethnicity,
aged 30–45 years, and with a length of service of at least 1 year. Subjects were excluded if, at the time
of the visit, they were affected by cancer, neurological diseases (e.g., multiple sclerosis, Alzheimer’s or
Parkinson’s disease, epilepsy), or acute relapses of systemic diseases (e.g., cardiovascular diseases,
diabetes). Other exclusion criteria were: antihypertensive or steroid drug assumption, pregnancy or
menopausal status, and body mass index (BMI) >30.
Current night shift workers were defined as workers who had been employed in shifts including
nights for at least 2 years, and were matched to non-night shift workers by age and length of service.
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2.2. Collection of Personal Data and Biological Samples
After all subjects gave their consent to participate in the study, they underwent a semi-structured
interview, which included a modified version of the Standard Shiftwork Index [26], to collect information
on demographic characteristics, health status (current or past diseases, medical drugs, etc.), lifestyle
(diet, alcohol consumption, smoking habit, etc.), occurrence of breast cancer among family members,
gynecological history (parity, oral contraceptive use, characteristics of the menstrual cycle, etc.), and
work (job title, length of service, etc.), with a particular focus on shift work schedule and duration.
Each subject was withdrawn a 12 ml blood sample for subsequent laboratory analyses (see below).
Blood collection (in EDTA tubes) occurred at the end of the night shift (between 7:15 and 7:45 in the
morning) for night shift workers and at the beginning of the day shift for non-night shift workers.
2.3. DNA Extraction and Methylation Analysis
Genomic DNA was isolated from buffy coat using a commercial kit (Wizard Genomic DNA
Purification Kit, Promega, Madison, WI, USA) following manufacturer procedures, and aliquoted at a
concentration of 25 ng/µL.
The analysis of DNA methylation was performed following a slightly modified version of a
previously described procedure [27]. Briefly, 500 ng of DNA (concentration 25 ng/µL) were treated with
EZ DNA Methylation-Gold™ Kit (Zymo Research, Orange, CA, USA) according to the manufacturer’s
protocol. Bisulphite-treated DNA was eluted in 300 µl of M-Elution Buffer. PCR reactions (50 µL
volume) were carried out with 25 µL of Hot Start GoTaq Green Master mix (Promega), 1 pmol of
forward primer, 1 pmol of reverse primer and 25 ng of bisulfite-treated genomic DNA. PCR cycling
conditions and primer sequences are provided in Table S1; CpG islands analyzed for gene-specific
methylation are reported in Table S2. Biotin-labeled primers (forward or reverse, depending on the
assay) were used to purify the final PCR product with Sepharose beads. The PCR product was bound to
Streptavidin Sepharose beads (Amersham Biosciences, Uppsala, Sweden), purified, washed, denatured
with 0.2 M NaOH, and washed again with the Pyrosequencing Vacuum Prep Tool (Pyrosequencing, Inc.,
Westborough, MA, USA), according to manufacturer’s instructions. Pyrosequencing primer (0.3 µM)
was annealed to the purified single-stranded PCR products, and pyrosequencing was performed
with the PyroMark MD System (Pyrosequencing, Inc. Westborough, MA, USA). Methylation levels
were expressed as the percentage of cytosines that were methylated, determined as the number of
methylated cytosines divided by the sum of methylated and unmethylated cytosines, multiplied by
100 (% 5-methyl-Cytosine).
2.4. Telomere Length Analysis
Telomere length was measured by Real-time PCR, according to methods described
previously [28–30]. In brief, the relative telomere length was measured by determining the ratio of
telomeric repeat copy number (T) to a nuclear single copy gene (S, human beta-globin gene, HBB) copy
number (T/S ratio) in a given sample relative to a reference pooled DNA used to generate a standard
curve, which was inserted in each PCR run. Primer sequences have been reported elsewhere [28]. The
reference pool DNA was prepared from 10 DNA samples (1µg DNA for each sample). A fresh standard
curve prepared from the pooled DNA, ranging from 24 ng/µL to 0.1875 ng/µL (serial dilutions 1:2),
was included in every “T” and “S” PCR run. For each sample, 22.5 ng of DNA were used as template
and each reaction was run tripled. All PCR reactions were performed on a 7900HT Fast Real-Time PCR
System (Applied Biosystems, Waltham, MA USA). At the end of each real-time PCR reaction, a melting
curve was added in order to confirm the amplification specificity and the absence of primer dimers.
The average of the three T measurements was divided by the average of the three S measurements to
calculate the T/S ratio for each sample.
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2.5. Statistical Analysis
We used standard descriptive statistics [means, standard deviations (SDs), and proportions] to
summarize data. Differences in variables distribution between current night shift workers vs. non-night
shift workers were assessed using Student’s t for continuous variables and chi-squared and Fisher’s
exact tests for categorical variables. Association between DNA methylation, telomere length and night
shift work [either considered as current vs. non-night shift workers or as ever vs. never night shift
workers] was assessed by applying linear regression models both unadjusted and adjusted for age,
BMI, smoking habit (current vs. former/never), and oral contraceptive use (yes vs. no). Since we
missed information on age at first pregnancy, we created an interaction term between parity and a
variable identifying marital status/age at marriage (0 = not married, 1 = married at 30 years of age or
older, 2 = married at an age between 25 and 29 years, 3 = married at less than 25 years of age), which
we additionally adjusted for in the models.
To study the association between the total duration of night shift work (in current and former
night shift workers) and the molecular outcomes of interest, we flexibly modeled the variable “number
of years in night shifts” (NYNS) as a restricted cubic spline with four knots at values 0, 6, 9, and 17
(corresponding to the 10th/25th, 50th, 75th, and 90th percentile of the variable distribution, respectively).
We then fitted a regression model including the splines, all the above mentioned adjustment covariates
(i.e., age, BMI, smoking habit, oral contraceptive use, and an interaction term between parity and
marital status/age at marriage), and a dichotomous variable identifying ever vs. never night shift
workers, and plotted the results to inspect data patterns. If a particular pattern was evident, we
additionally fit linear spline models (with the same adjustment variables) allowing the slope of the
function to change at predefined bending points, to better capture and describe the most prominent
features of the exposure-response association.
Results were expressed as regression coefficients (β), which take the unit of measure of the
investigated outcome variable (i.e., methylation percentage or telomere length), and corresponding
95% confidence intervals (95% CI). Analyses were performed using STATA (StataCorp. 2017. Stata
Statistical Software: Release 15. College Station, TX: StataCorp LLC).
3. Results
We recruited 46 current night shift workers and 51 workers not currently employed in night shifts,
whose main characteristics are summarized in Table 1. Our study population had a mean age of
35.9 years (± 5.4) and an average length of service of 11.7 years (± 6.9): these two variables, together
with BMI, did not significantly vary between the two groups. Night shift workers smoked and used
oral contraceptives in slightly higher proportions, and 89% of them did not have children (p = 0.003).
Twenty-three non-night shift workers had previously worked in night shifts. Among ever night
shift workers with available information (N = 66), mean NYNS was 9.5 (± 5.3), with a minimum of 2
and a maximum of 24 years.
Summary statistics for DNA methylation (%) and telomere length (T/S) are reported in Table S3.
When investigating whether current night shift work could influence DNA methylation or
telomere length, the fully adjusted regression models mostly returned null results, except for a clear
reduction in the methylation of ESR1 associated with current night shifts, which was confirmed in
both unadjusted (β = −1.67, 95%CI: −2.58 ; −0.76, p <0.001) and adjusted (β = −1.85, 95%CI: −3.03 ;
−0.67, p = 0.003) models (Table 2).
Similar results for ESR1 associated with night shift work were obtained also when considering
both current and former night shift workers, with an adjusted regression coefficient of −1.52 (95%CI:
−2.81; −0.22, p = 0.02). This analysis also showed a hypomethylation in TP53 (β = −0.93, 95%CI: −1.73;
−0.12, p = 0.03) and BRCA1 (β = −1.14, 95%CI: −1.71 ; −0.58, p <0.001) among ever night shift workers.
No other pattern was apparent, except for an increase in the methylation of ESR2 associated with night
shifts that, however, presented very wide confidence intervals and was far from statistical significance
(Table 3).
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Table 1. Characteristics of the study population.
Characteristic Current night shift
Mean ± SD, N (%) Total No (51) Yes (46) p *
Age 35.9 ± 5.4 36.5 ± 5.3 35.3 ± 5.6 0.31
Length of service 11.8 ± 6.9 12.7 ± 7.3 10.7 ± 6.3 0.17
BMI 22.7 ± 3.2 22.2 ± 3.3 23.2 ± 3.0 0.14
Smoking habit
Former/Never 67 (71.3) 38 (76.0) 29 (65.9)
Current 27 (28.7) 12 (24.0) 15 (34.1) 0.36
Oral contraceptive use
No 58 (63.0) 33 (67.4) 25 (58.1)
Yes 34 (37.0) 16 (32.6) 18 (41.9) 0.36
Number of children
0 70 (72.1) 29 (56.9) 41 (89.1)
1 12 (12.4) 10 (19.6) 2 (4.4)
2+ 15 (15.5) 12 (23.5) 3 (6.5) 0.002
Marital status/Age at marriage
Not married 55 (56.7) 24 (47.1) 31 (67.4)
Married at 30+ years 16 (16.5) 11 (21.6) 5 (10.9)
Married at 25–29 years 20 (20.6) 12 (23.5) 8 (17.4)
Married at <25 years 6 (6.2) 4 (7.8) 2 (4.3) 0.23
SD: standard deviation. * Student’s t test for continuous variables, chi-squared and Fisher’s exact tests for
categorical variables.
Table 2. Association between night shift work [current (N = 46) vs. non-night shift workers (N = 51)]
and gene-specific methylation, methylation of repetitive elements, and telomere length.
Biological Markers
Unadjusted Adjusted *
β (95%CI) p β (95%CI) p
TP53 −0.32 (−0.93 ; 0.30) 0.31 −0.19 (−0.97 ; 0.59) 0.63
CDKN2A 0.25 (−0.12 ; 0.62) 0.19 0.16 (−0.26 ; 0.58) 0.46
BRCA1 −0.68 (−1.13 ; −0.23) 0.004 −0.42 (−1.00 ; 0.15) 0.15
BRCA2 −0.07 (−0.92 ; 0.78) 0.87 −0.15 (−1.26 ; 0.95) 0.78
ESR1 −1.67 (−2.58 ; −0.76) <0.001 −1.85 (−3.03 ; −0.67) 0.003
ESR2 −0.12 (−3.13 ; 2.88) 0.94 0.47 (−3.24 ; 4.18) 0.80
LINE-1 −0.17 (−0.58 ; 0.24) 0.40 −0.16 (−0.66 ; 0.34) 0.52
Alu 0.30 (−0.25 ; 0.85) 0.29 −0.12 (−0.73 ; 0.50) 0.71
TL 0.03 (−0.07 ; 0.14) 0.53 0.05 (−0.07 ; 0.18) 0.39
TL: telomere length. * Linear regression models adjusted for age, BMI, smoking habit, oral contraceptive use, and an
interaction term between parity and marital status/age at marriage.
Table 3. Association between night shift work (ever (N = 69) vs. never (N = 28) night shift workers)
and gene-specific methylation, methylation of repetitive elements, and telomere length.
Biological Markers
Unadjusted Adjusted *
β (95%CI) p β (95%CI) p
TP53 −0.85 (−1.50 ; −0.20) 0.01 −0.93 (−1.73 ; −0.12) 0.03
CDKN2A 0.22 (−0.18 ; 0.63) 0.27 0.09 (−0.37 ; 0.54) 0.71
BRCA1 −1.25 (−1.70 ; −0.80) <0.001 −1.14 (−1.71 ; −0.58) <0.001
BRCA2 −0.09 (−1.01 ; 0.83) 0.85 −0.31 (−1.47 ; 0.85) 0.60
ESR1 −1.53 (−2.55 ; −0.51) 0.004 −1.52 (−2.81 ; −0.22) 0.02
ESR2 1.63 (−1.59 ; 4.85) 0.32 2.52 (−1.38 ; 6.43) 0.20
LINE-1 −0.58 (−1.02 ; −0.15) 0.009 −0.42 (−0.96 ; 0.11) 0.12
Alu −0.001 (−0.61 ; 0.61) 0.99 −0.13 (−0.79 ; 0.53) 0.70
TL 0.02 (−0.10 ; 0.14) 0.70 0.03 (−0.10 ; 0.17) 0.64
TL: telomere length. * Linear regression models adjusted for age, BMI, smoking habit, oral contraceptive use, and an
interaction term between parity and marital status/age at marriage.
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Spline models did not show evidence of an association between NYNS in current and former night
shift workers and the investigated epigenetic outcomes, with curves depicting the exposure-response
function that were mostly flat (Figures S1–S8). On the other hand, the model inspecting the relationship
between NYNS and telomere length did show a pattern of the data, with an increase in telomere length
for values of NYNS up to about 12 years, and a subsequent decrease (Figure 1).
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Figure 1. Association* between number of years in night shifts and telomere length.* Number of years
in night shifts modeled as a restricted cubic spline with four knots at values 0, 6, 9, 17; other variables
in the model include ever/never night shifts, age, BMI, smoking habit, oral contraceptive use, and an
interaction term between parity and marital status/age at marriage.
We then modeled the variable NYNS as a linear spline allowing the slope of the function to
change at 12 years: we observed an increase in telomere length in subjects having worked in night
shifts for less than 12 years (β = 0.06, 95%CI: 0.03 ; 0.09, p <0.001) and a decrease in nurses employed
in night shifts for 12 years or more (β = −0.07, 95%CI; −0.10 ; −0.04, p <0.001). No association was
observed between linear splines of NYNS and the other investigated epigenetic outcomes (Table S4).
A sensitivity analysis restricted to ever night shift workers returned similar results (not shown).
4. Discussion
In a study including almost 100 female nurses, we documented an association between night shift
work and epigenetic and molecular alterations potentially related to a higher carcinogenic risk.
In particular, we observed a reduced methylation of ESR1 associated with night shift work, both
when analyzing current night shift workers vs. non-night shift workers, and when comparing ever
vs. never night shift workers. A recent study on breast cancer cells suggested that low levels of ESR1
promoters methylation may favor ESR1 gene expression (mediated by binding of progesterone to the
promoter region) [31]. ESR1 encodes estrogen-receptor [ER] alpha, whose stimulation by estrogens is
known to be associated with an increased proliferation of breast tissue [32]. Our results might thus
indicate an increased breast tissue sensitivity to estrogenic stimulation, which is a well-known risk
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factor for breast cancer [33]. A recent cohort study on over 400 Chilean girls found methylation of the
ER-Alpha gene to be inversely associated with some indicators of breast composition, including total
breast volume, fibroglandular volume, and percent fibroglandular volume. Since increased proportion
of dense breast tissue in adults represents a strong risk factor for breast cancer [34], the authors suggest
that the methylation profile of ESR1 may modulate adolescent response to estrogen and may thus
influence breast cancer risk in adulthood [35]. Although our population is older, this evidence might
contribute to interpret our results in the light of the complex relationship between estrogen sensitivity
and increased cancer risk. In addition, our results on ESR1 might also represent a signal of altered
melatonin secretion, which has been extensively documented in night shift workers [36], as melatonin
is considered to play a role in the regulation of the ER expression [37].
When including in our analyses current and former night shift workers, we observed a
reduced methylation of TP53 and BRCA1 genes, both encoding tumor suppressors that prevent
the transformation of normal cells to cancer cells: p53 (encoded by TP53 gene) regulates cell-cycle
progression by means of several mechanisms, such as apoptosis, senescence, DNA repair and
differentiation [38]; BRCA1 is a well-known breast cancer susceptibility gene, and its encoded protein
(together with that of BRCA2) is involved in the repair of chromosomal damage, displaying its functions
in the error-free repair of DNA double-strand breaks [39]. Although not directly related to breast
cancer, some evidences have been suggesting that hypomethylation of BRCA1 might be associated
with an increased carcinogenic risk. In particular, a case-control study conducted in France found
significantly decreased BRCA1 methylation in peripheral blood cells of 51 sporadic ovarian cancer
cases compared with 349 healthy female controls [40]. Given all the above, we could speculate that
reduction of TP53 and BRCA1 methylation might be induced to counterbalance defects in circadian
cell-cycle regulation which are possibly involved in uncontrolled cell growth, in night shift workers.
These findings might be part of a bigger picture where long-term night shift work has been associated
with diverse epigenetic alterations [41].
We observed a reduced telomere length with increasing NYNS in nurses with at least 12 years of
night shifts. Genomic instability following telomere shortening is a well-established mechanism of
tumor development [20] and some studies documented an increased cancer risk among subjects with
reduced telomere length [42]. Nonetheless, available data on the association between telomere length
and breast cancer still remain inconsistent [43–45]. On the other hand, findings correlating telomere
shortening with breast cancer stage and progression seem more coherent [46–48]. In particular, the
finding on telomere shortening in subjects with longer duration of total night shift work is concordant
with a recent case-control study conducted on more than 560 breast cancer cases and about 600 controls,
which showed a reduced telomere length in female nurses employed in (consecutive) night shifts for at
least 5 years [49].
We did not find any significant association between night shift work and methylation of repetitive
elements in adjusted models; these null findings are somewhat similar to what observed in another
investigation conducted by our research team on a group of 150 workers, including 100 shift workers,
which did not show any evidence of a relationship between shift work and methylation of either
LINE-1 or Alu [50]. On the other hand, a recent study conducted on a tissue-isolated xenograft model of
human prostate cancer showed that LINE-1 expression was suppressed by melatonin [51], and that the
overexpression of melatonin receptor 1 suppressed LINE-1 and Alu mobilization (driven by LINE-1) in
cancer cells; the authors hypothesized that loss of LINE-1 regulation following light at night exposure
(and subsequent suppression of melatonin production) might represent an underlying mechanism
for the higher cancer incidence rates in people experiencing light at night, such as shift workers [52].
However, evidences produced on this specific topic are still scarce and preclude firm conclusions.
Our work has several strengths. First of all, it looks at various molecular outcomes in the attempt
to offer some insights in the understanding of the mechanisms that might underlie the association
between night shift work and breast cancer. As we used flexible models to evaluate the relationship
between molecular markers and a surrogate of cumulative exposure such as NYNS, we did not
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constrain our data to a priori assumptions on the linearity of the investigated associations [53]. Still, the
use of linear splines allowed us to describe more easily the most prominent features of the association
between NYNS and the analyzed outcomes, telomere length in particular. In addition, we were able
to adjust for several individual confounders, including parity and a proxy for age at first pregnancy,
which are both known to influence breast cancer risk [54].
Our study has also limitations. The small number of the recruited subjects hampers our findings
with some uncertainty and precludes sound conclusions. Secondly, all information regarding the main
exposure of interest (i.e. characteristics of the shifts) as well as all the confounders were self-reported,
even if the absence of a pathologic outcome should bring to avoid major distortions. Thirdly, the
characterization of the exposure lacked some important pieces of information (such as number of
subsequent night shifts, precise scheme of the shift schedule, etc.). Lastly, the changes we observed are
small in size; nonetheless, apparently small methylation differences (when expressed as percentage
over the total number of cytosine in the considered position) involve indeed many blood cells and a
large number of DNA molecules whose expression might be altered.
5. Conclusions
Our findings, although preliminary and based on a small sample, suggest an association between
prolonged exposure to night shifts and molecular alterations that might be involved in processes such
as cellular aging, genomic instability, and cancer development. Further studies on larger homogenous
working populations are warranted (if possible with collection of biological samples), together with a
better exposure assessment, taking into account not only the overall duration of night shift work (i.e.,
the cumulative exposure), but also its intensity, its schedule (including data on resting periods) and,
when feasible, information regarding the chronotype of the study population.
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